We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Norwood Imm. | LSE:NIM | London | Ordinary Share | AU000A0CANX1 | ORD SHS NPV |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:5914C
Norwood Immunology Ld
21 August 2007
NORWOOD IMMUNOLOGY LIMITED
Company Website
Norwood Immunology Limited ("the Company") (AIM:NIM) is pleased to announce
that, for the purposes of compliance with AIM Rule 26, details of the Company
are available on: http://www.norwoodimmunology.com/
For further information contact:
Richard Williams, Chief Executive Officer, Norwood Immunology Limited
www.norwoodimmunology.com
+44 (0)7860 295153
Richard Scarrott, Chief Financial Officer, Norwood Immunology Limited
www.norwoodimmunology.com
+44 (0)7785 355909
Capel Irwin, Nicholas Marren, KBC Peel Hunt Ltd (Nominated Adviser and Broker)
+44 (0)207 418 8915
Lisa Baderoon, Buchanan Communications
+44 (0)207 466 5000
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAKPFASKXEFE
1 Year Norwood Immunology Chart |
1 Month Norwood Immunology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
